Categories: News

BBS-Bioactive Bone Substitutes Oyj – Managers’ Transactions – Pekka Jalovaara

BBS-Bioactive Bone Substitutes Plc, Company announcement, management transactions, 7 August 2023 at 16.00 (EEST)

BBS-Bioactive Bone Substitutes Oyj Managers’ Transactions – Pekka Jalovaara

This Company announcement contains information on the following management transactions:

  • Subscription of shares with warrants (TO1) 5 December 2022
  • Subscription of shares with warrants (TO2) 29 May 2023
  • Subscription of shares in share issue on 26 June 2023
  • Received shares without consideration on 11 July 2023 (directed share issue without consideration, release 7 June 2023)

____________________________________________

Person subject to the notification requirement

Name: Jalovaara Pekka

Position: Member of the Board/Deputy member

Issuer: BBS Bioactive Bone Substitutes Oyj

LEI: 743700BYSBP0PCR6N767

Notification type: INITIAL NOTIFICATION

Reference number: 743700BYSBP0PCR6N767_20230803191449_6

____________________________________________

Transaction date: 2022-12-05

Venue not applicable

Instrument type: SHARE

ISIN: FI4000260583

Nature of the transaction: SUBSCRIPTION

(X) Linked to stock option programme

Transaction details

(1): Volume: 1,925 Unit price: 0.92 EUR

Aggregated transactions

(1): Volume: 1,925 Volume weighted average price: 0.92 EUR

____________________________________________

Transaction date: 2023-05-29

Venue not applicable

Instrument type: SHARE

ISIN: FI4000260583

Nature of the transaction: SUBSCRIPTION

(X) Linked to stock option programme

Transaction details

(1): Volume: 1,925 Unit price: 0.65 EUR

Aggregated transactions

(1): Volume: 1,925 Volume weighted average price: 0.65 EUR

____________________________________________

Transaction date: 2023-06-26

Venue not applicable

Instrument type: SHARE

ISIN: FI4000260583

Nature of the transaction: SUBSCRIPTION

Transaction details

(1): Volume: 7,200 Unit price: 0.5 EUR

(2): Volume: 4,020 Unit price: 0.5 EUR

Aggregated transactions

(2): Volume: 11,220 Volume weighted average price: 0.5 EUR

____________________________________________

Transaction date: 2023-07-11

Venue not applicable

Instrument type: SHARE

ISIN: FI4000260583

Nature of the transaction: OTHER

Description: Received shares without consideration on 11 July 2023 (directed share issue without consideration, release 7 June 2023)

Transaction details

(1): Volume: 385 Unit price: 0.00 EUR

Aggregated transactions

(1): Volume: 385 Volume weighted average price: 0.00 EUR

____________________________________________

Contact information:

Ilkka Kangasniemi, CEO
040 708 0307
ilkka.kangasniemi@bbs-artebone.fi

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

1 hour ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

1 hour ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

1 hour ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

1 hour ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

1 hour ago